Diagnostic Center | March 12, 2024
Pfizer announces positive Phase 3 trial of ADCETRIS regimen in patients with DLBCL
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
At present 18 per cent of the local pharmaceutical market is under government's price control
Lenalidomide is used to treat cancer and also some anaemia disorders
Subscribe To Our Newsletter & Stay Updated
